Proliferating endothelial cells, but not microvessel density, are a prognostic parameter in human cutaneous melanoma

Melanoma Research

Volumn 16, Issue 5, 2006, Pages 453-457

  Hillen, Femke ^a   Van De Winkel, Anouk ^a   Creytens, David ^a   Vermeulen, Anton H M ^a   Griffioen, Arjan W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Cutaneous melanoma; Microvessel density; Prognosis; Proliferating endothelial cells

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; METASTASIS; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; SKIN TUMOR; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; ANTIGENS, CD34; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MELANOMA; MICROCIRCULATION; MIDDLE AGED; SKIN NEOPLASMS;

EID: 33749430780     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cmr.0000232291.68666.4c     Document Type: Article

References (43)

1. Levi F, Lucchini F, Negri E, Boyle P, La VC. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer 2004; 110:155-169.
2. La VC, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 1999; 81:62-66.
3. de VE, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004; 40:2355-2366.
4. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med 2004; 351:998-1012.
5. Li N, Mangini J, Bhawan J. New prognostic factors of cutaneous melanoma: a review of the literature. J Cutan Pathol 2002; 29:324-340.
6. Slingluff CL Jr, Vollmer RT, Reintgen DS, Seigler HF. Lethal 'thin' malignant melanoma. Identifying patients at risk. Ann Surg 1988; 208:150-161.
7. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-364.
8. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
9. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 2002; 38:1564-1579.
10. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995; 177:275-283.
11. Fox SB, Harris AL. Histological quantitation of tumour angiogenesis. Acta Pathol Microbiol Immunol Scand 2004; 112:413-430.
12. Wild R, Ramakrishnan S, Sedgewick J, Griffioen AW. Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density. Microvasc Res 2000; 59:368-376.
13. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996; 32A:2474-2484.
14. Vermeulen PB, Verhoeven D, Hubens G, Van ME, Goovaerts G, Huyghe M, et al. Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas. Ann Oncol 1995; 6:59-64.
15. Mooi WJ, Krausz T. Biopsy pathology of melanocytic disorders. London, UK: Chapman & Hall Medical; 1992.
16. Warren BA, Shubik P. The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab Invest 1966; 15:464-478.
17. Hubler WR Jr, Wolf JE Jr. Melanoma. Tumor angiogenesis and human neoplasia. Cancer 1976; 38:187-192.
18. Srivastava A, Laidler P, Hughes LE, Woodcock J, Shedden EJ. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 1986; 22:1205-1209.
19. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 1988; 133:419-423.
20. Fallowfield ME, Cook MG. The vascularity of primary cutaneous melanoma. J Pathol 1991; 164:241-244.
21. Barnhill RL, Levy MA. Regressing thin cutaneous malignant melanomas (
22. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS, White WL. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol 1994; 145:510-514.
23. Marcoval J, Moreno A, Graells J, Vidal A, Escriba JM, Garcia-Ramirez M, et al. Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase. J Cutan Pathol 1997; 24:212-218.
24. Vlaykova T, Muhonen T, Hahka-Kemppinen M, Pyrhonen S, Jekunen A. Vascularity and prognosis of metastatic melanoma. Int J Cancer 1997; 74:326-329.
25. Erhard H, Rietveld FJ, van Altena MC, Brocker EB, Ruiter DJ, de Waal RM. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis. Melanoma Res 1997; 7 (Suppl 2):S19-S26.
26. Straume O, Salvesen HB, Akslen LA. Angiogenesis is prognostically important in vertical growth phase melanomas. Int J Oncol 1999; 15:595-599.
27. de Waal RM, van Altena MC, Erhard H, Weidle UH, Nooijen PT, Ruiter DJ. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. Am J Pathol 1997; 150:1951-1957.
28. Straume O, Akslen LA. Expression of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. Am J Pathol 2001; 159:223-235.
29. Zamolo G, Gruber F, Cabrijan L, Micovic V, Iternicka Z, Jonjic N. Influence of tumor thickness and vascularity on survival in cutaneous melanoma. Acta Med Okayama 2001; 55:289-293.
30. Kashani-Sabet M, Sagebiel RW, Ferreira CM, Nosrati M, Miller JR 3rd. Tumor vascularity in the prognostic assessment of primary cutaneous melanoma. J Clin Oncol 2002; 20:1826-1831.
31. Ribatti D, Ennas MG, Vacca A, Ferreli F, Nico B, Orru S, et al. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest 2003; 33:420-425.
32. Valencak J, Heere-Ress E, Kopp T, Schoppmann SF, Kittler H, Pehamberger H. Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. Eur J Cancer 2004; 40:358-364.
33. Carnochan P, Briggs JC, Westbury G, Davies AJ. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness. Br J Cancer 1991; 64:102-107.
34. Barnhill RL, Busam KJ, Berwick M, Blessing K, Cochran AJ, Elder DE, et al. Tumour vascularity is not a prognostic factor for cutaneous melanoma. Lancet 1994; 344:1237-1238.
35. Guffey JM, Chaney JV, Stevens GL, Schroer KR, Fenske NA, Reintgen D, et al. Immunohistochemical assessment of tumor vascularity in recurrent Clark II melanomas using antibody to type IV collagen. J Cutan Pathol 1995; 22:122-127.
36. Busam KJ, Berwick M, Blessing K, Fandrey K, Kang S, Karaoli T, et al. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 1995; 147:1049-1056.
37. Pierard GE, Pierard-Franchimont C. Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas. Eur J Cancer 1997; 33:1888-1892.
38. Massi D, Franchi A, Borgognoni L, Paglierani M, Reali UM, Santucci M. Tumor angiogenesis as a prognostic factor in thick cutaneous malignant melanoma. A quantitative morphologic analysis. Virchows Arch 2002; 440:22-28.
39. Jonjic N, Zamolo G, Stifter S, Fuckar D, Gruber F, Sasso F, et al. Cytomorphological variations, proliferation and angiogenesis in the prognosis of cutaneous melanoma. Clin Exp Dermatol 2003; 28:310-314.
40. Auguste P, Lemiere S, Larrieu-Lahargue F, Bikfalvi A. Molecular mechanisms of tumor vascularization. Crit Rev Oncol Hematol 2005; 54:53-61.
41. Braverman IM. The cutaneous microcirculation. J Investig Dermatol Symp Proc 2000; 5:3-9.
42. Dome B, Paku S, Somlai B, Timar J. Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance. J Pathol 2002; 197:355-362.
43. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002; 94:883-893.